LEWIS JOEL

Average Profitability
<0.0001%
Insider Buys Quantity
7
Insider Buys Sum
$79,465.29
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of LEWIS JOEL

According to the SEC Form 4 filings, LEWIS JOEL, being in a position of

  1. President and CEO at Galectin Therapeutics Inc.,
    оver the last 12 months, has bought 1000 shares for $3,390, and sold 0 shares,
    over all time since 2018-06-25, has bought 18516 shares for $79,465, and sold 0 shares.

The largest purchase of all time was on 2019-05-31 and amounted to 12849 shares of Galectin Therapeutics Inc. for $54,994.

Biography of LEWIS JOEL

No biography is available at this moment.

2024-04-24PurchaseGalectin Therapeutics Inc.
GALT
President and CEO
1,000
0.0016%
$3.39$3,390-17.93%
2023-02-16PurchaseGalectin Therapeutics Inc.
GALT
1,000
0.0017%
$1.52$1,520+17.33%
2019-05-31PurchaseGalectin Therapeutics Inc.
GALT
director
12,849
0.0271%
$4.28$54,994-23.33%
2019-04-05PurchaseGalectin Therapeutics Inc.
GALT
director
667
0.0013%
$4.82$3,214-24.74%
2019-02-07PurchaseGalectin Therapeutics Inc.
GALT
director
1,000
0.0022%
$4.48$4,484-13.53%
2019-01-29PurchaseGalectin Therapeutics Inc.
GALT
director
1,000
0.0021%
$4.80$4,805-21.54%
2018-06-25PurchaseGalectin Therapeutics Inc.
GALT
director
1,000
0.0026%
$7.06$7,058-31.42%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.